The regulatory file for L-ornithine hydrochloride
L-Ornithine hydrochloride is a food ingredient whose regulatory file depends on the destination and the finished product, not only on the certificate. The file has to name the exact form, CAS 3184-13-2, connect it to a route, convert the contaminant limits to the daily dose, and match the label to the salt. The buyer's regulatory team confirms the route; this page lists the documents and checks that belong in the folder.
The certificate describes the lot; the regulatory file has to connect the hydrochloride, the destination and the label, and the buyer's team signs that route.
The file, not the certificate
A supplier can hand over a COA, a specification and a safety data sheet without answering the market question. The file has to connect those documents to an instrument, a destination and a finished-product dose. The form is the first line of that connection: a document written for L-ornithine free base (CAS 70-26-8) does not describe the hydrochloride (CAS 3184-13-2), and the reverse is also true.
| Market | Instruments | What they decide |
|---|---|---|
| European Union | Directive 2002/46/EC; Regulations 178/2002, 2015/2283, 2023/915, 1169/2011 and 1924/2006 | Supplement status, novel-food history, contaminants, labelling and claims |
| United States | FD&C Act section 201(ff) as amended by DSHEA; 21 CFR 111, 101.36, 101.93 and 190.6 | Dietary-ingredient basis, cGMP, Supplement Facts and structure/function statements |
| United Kingdom | Retained food law, including the 2003 supplement rules and the 2014 food information rules | Sale and labelling in Great Britain; Northern Ireland uses the EU regime |
The certificate is a lot document, not an authorisation. The specification describes the material, the SDS describes handling, and neither speaks for the destination. Keep a versioned document list at the front of the folder.
European Union
Directive 2002/46/EC harmonises the vitamins and minerals permitted in food supplements; ornithine is not in Annexes I or II, so the member state where the product is sold decides whether a maximum level, a notification or a form restriction applies. The same capsule can be routine in one member state and need a filing in another, and the hydrochloride is a separate material from the free base for that review.
Novel food is a separate gate. Regulation (EU) 2015/2283 turns on documented use before 15 May 1997, and the file needs the evidence behind that claim for the exact form, not a conclusion carried over from another salt. Labelling follows Regulation (EU) No 1169/2011 and the supplement particulars; contaminants fall under Regulation (EU) 2023/915. The current consolidated texts are the reference, and the EU regulatory notes collect the framework.
United States
In the US, section 201(ff) of the FD&C Act allows an amino acid to be sold as a dietary ingredient. The lawful basis is either marketing before 15 October 1994 or a new dietary ingredient notification under 21 CFR 190.6; the supplier should name the basis it relies on, and the buyer checks that it covers the salt and the finished product. Identity testing of each component is the manufacturer's duty under 21 CFR 111.
The Supplement Facts panel follows 21 CFR 101.36 and declares the amount per serving; ornithine has no Daily Value, so no percentage appears beside it. A structure or function statement needs substantiation and the disclaimer in 21 CFR 101.93, and it must stop short of a disease-related claim. The FDA does not clear a label before sale, so the substantiation file is the brand's defence.
Contaminants and the finished dose
The catalog limits are specification terms; the regulatory question is the exposure from the finished product. The table below pairs the catalog limit with the calculation the file should show.
| Element | Catalog limit | What the file should show |
|---|---|---|
| Lead (Pb) | ≤3 mg/kg | Lot result, method and the daily-dose calculation |
| Cadmium (Cd) | ≤1 mg/kg | Lot result and any category exception |
| Mercury (Hg) | ≤0.1 mg/kg | Lot result and method |
| Arsenic (As) | ≤2 mg/kg | The agreed limit and the method |
A powder that meets the catalog can still fail the finished product, because the daily dose and the other ingredients add to the exposure. Convert each result to the daily dose, keep the margin, and record the calculation in the file. In the US, as of this review, no federal lead ceiling applies to supplements; state rules such as Proposition 65 work from the daily dose and have to be checked separately.
Claims and the form
In the EU and the UK, Regulation (EC) No 1924/2006 governs health claims, and a wording must be in the register before it is used. As of this review the register has no authorised claim for L-ornithine; the 2011 EFSA opinion on the urea-cycle claim did not establish the relationship. The current register is the reference, not this summary, and the salt form does not create a claim that the free base lacks.
The US allows a structure or function statement with the DSHEA disclaimer, provided the brand holds substantiation. A compositional statement such as "L-ornithine hydrochloride 500 mg per capsule" is a different thing: it describes the product and has to match the certificate, but it does not authorise a health claim. No disease-related claim is open in either market, and this site publishes the specification only.
Documents for the file
- A lot COA with the titration assay calculated as the hydrochloride, the basis, the rotation conditions and the mesh result; the lot code must match the pack.
- The current specification, naming L-ornithine hydrochloride, CAS 3184-13-2 and the particle size.
- A safety data sheet, an allergen statement and a food-contact declaration for the pouch or liner.
- A manufacturer and country-of-origin statement that names the production site.
- Novel-food evidence for the exact form, and a US statement of the dietary-ingredient basis.
- A chloride result where the form is to be confirmed analytically, and a stability summary for the pack sold.
- Halal or kosher certificates where the market requires them, and a residual-solvent statement if the route uses one.
Checklist before the first order
- Name the destination, and for the EU the member state.
- Confirm the specification and the label both say hydrochloride, not the free base.
- Find the destination's level, notification and novel-food position for the exact form.
- Convert each contaminant limit to the finished daily dose and record the margin.
- Check the declared quantity against the assay entity and the salt-to-ornithine conversion.
- Search the current claims register, or review the US substantiation file.
- Keep one version across the specification, the certificate and the artwork.
The product hub carries the catalog specification; the COA page shows the lot certificate; the identity page covers the analytical evidence; the US regulatory page and the quality page complete the folder.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation